18 August 2024 : Review article
Optimizing Mesenchymal Stem Cells for Regenerative Medicine: Influence of Diabetes, Obesity, Autoimmune, and Inflammatory Conditions on Therapeutic Efficacy: A Review
Dominika Przywara1ABCDEF, Alicja PetniakDOI: 10.12659/MSM.945331
Med Sci Monit 2024; 30:e945331
Table 1 Comparison of the effects of different types of diabetes on the properties of MSCs.
| Disease | Effects on MSCs | Predicted effect |
|---|---|---|
| Diabetic kidney disease | Stronger secretion of IDO and PGE2Weaker IL6 secretion []30 | Enhancing anti-inflammatory properties |
| Reduced ability to migrate []30 | Increased risk of cells not reaching the site of injury | |
| Increased proliferation []30 | Increased effectiveness of therapy due to the possibility of using a larger number of cells | |
| Gestational diabetes | Decreased proliferation []37 | Reduced effectiveness of therapy due to the possibility of using fewer cells |
| Increased p16 and p27 transcripts []37 | Faster cell aging | |
| Type 2 diabetes | Higher levels of pro-apoptotic markers []32 | Shorter cell survival time |
| Increased frequency of differentiation into adipocytes []34 | Limited differentiation capacity | |
| Higher expression []32 | Stimulation of the growth and development of adjacent tissues | |
| Increase in the number of M2 macrophages with a decrease in the number of M1 macrophages []36 | Increased anti-inflammatory properties | |
| Type 1 diabetes | Lower expression [,]31 | Weakening of pro-angiogenic properties, lower effectiveness of regeneration of adjacent tissues |
| Lower expression of and []35 | Faster aging of MSCs, lower efficiency of regeneration of adjacent tissues | |
| Lowering KLF2 []33 | Weakening of pro-angiogenic properties |






